Literature DB >> 28722610

Evaluation of a Spotted Fever Group Rickettsia Public Health Surveillance System in Tennessee.

Mary-Margaret A Fill1,2, Abelardo C Moncayo1, Karen C Bloch3,4, John R Dunn1, William Schaffner3, Timothy F Jones1.   

Abstract

Spotted fever group (SFG) rickettsioses are endemic in Tennessee, with ∼2,500 cases reported during 2000-2012. Because of this substantial burden of disease, we performed a three-part evaluation of Tennessee's routine surveillance for SFG rickettsioses cases and deaths to assess the system's effectiveness. Tennessee Department of Health (TDH) SFG rickettsioses surveillance records were matched to three patient series: 1) patients with positive serologic specimens from a commercial reference laboratory during 2010-2011, 2) tertiary medical center patients with positive serologic tests during 2007-2013, and 3) patients identified from death certificates issued during 1995-2014 with SFG rickettsiosis-related causes of death. Chart reviews were performed and patients were classified according to the Council of State and Territorial Epidemiologists' case definition. Of 254 SFG Rickettsia-positive serologic specimens from the reference laboratory, 129 (51%) met the case definition for confirmed or probable cases of rickettsial disease after chart review. The sensitivity of the TDH surveillance system to detect cases was 45%. Of the 98 confirmed or probable cases identified from the medical center, the sensitivity of the TDH surveillance system to detect cases was 34%. Of 27 patients identified by death certificates, 12 (44%) were classified as confirmed or probable cases; four (33%) were reported to TDH, but none were correctly identified as deceased. Cases of SFG rickettsioses were underreported and fatalities not correctly identified. Efforts are needed to improve SFG rickettsiosis surveillance in Tennessee.

Entities:  

Mesh:

Year:  2017        PMID: 28722610      PMCID: PMC5590572          DOI: 10.4269/ajtmh.16-0765

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  10 in total

1.  Passive surveillance as an instrument to identify risk factors for fatal Rocky Mountain spotted fever: is there more to learn?

Authors:  James E Childs; Christopher D Paddock
Journal:  Am J Trop Med Hyg       Date:  2002-05       Impact factor: 2.345

2.  Rocky Mountain spotted fever in the USA: a benign disease or a common diagnostic error?

Authors:  Didier Raoult; Philippe Parola
Journal:  Lancet Infect Dis       Date:  2008-10       Impact factor: 25.071

Review 3.  Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases.

Authors:  B La Scola; D Raoult
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

4.  Rocky mountain spotted fever in the United States, 2000-2007: interpreting contemporary increases in incidence.

Authors:  John J Openshaw; David L Swerdlow; John W Krebs; Robert C Holman; Eric Mandel; Alexis Harvey; Dana Haberling; Robert F Massung; Jennifer H McQuiston
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

5.  Risk factors for fatal outcome from rocky mountain spotted Fever in a highly endemic area-Arizona, 2002-2011.

Authors:  Joanna J Regan; Marc S Traeger; Dwight Humpherys; Dianna L Mahoney; Michelle Martinez; Ginny L Emerson; Danielle M Tack; Aimee Geissler; Seema Yasmin; Regina Lawson; Velda Williams; Charlene Hamilton; Craig Levy; Ken Komatsu; David A Yost; Jennifer H McQuiston
Journal:  Clin Infect Dis       Date:  2015-02-19       Impact factor: 9.079

6.  Fatal Rocky Mountain spotted fever in the United States, 1999-2007.

Authors:  F Scott Dahlgren; Robert C Holman; Christopher D Paddock; Laura S Callinan; Jennifer H McQuiston
Journal:  Am J Trop Med Hyg       Date:  2012-04       Impact factor: 2.345

7.  National Surveillance of Spotted Fever Group Rickettsioses in the United States, 2008-2012.

Authors:  Naomi A Drexler; F Scott Dahlgren; Kristen Nichols Heitman; Robert F Massung; Christopher D Paddock; Casey Barton Behravesh
Journal:  Am J Trop Med Hyg       Date:  2015-08-31       Impact factor: 2.345

8.  Antibodies reactive to Rickettsia rickettsii among children living in the southeast and south central regions of the United States.

Authors:  Gary S Marshall; Gordon G Stout; Richard F Jacobs; Gordon E Schutze; Helene Paxton; Steven C Buckingham; John P DeVincenzo; Mary Anne Jackson; Venusto H San Joaquin; Steven M Standaert; Charles R Woods
Journal:  Arch Pediatr Adolesc Med       Date:  2003-05

9.  Human Infections by Multiple Spotted Fever Group Rickettsiae in Tennessee.

Authors:  Josie Delisle; Nicole L Mendell; Annica Stull-Lane; Karen C Bloch; Donald H Bouyer; Abelardo C Moncayo
Journal:  Am J Trop Med Hyg       Date:  2016-03-28       Impact factor: 2.345

10.  Expanding Range of Amblyomma americanum and Simultaneous Changes in the Epidemiology of Spotted Fever Group Rickettsiosis in the United States.

Authors:  F Scott Dahlgren; Christopher D Paddock; Yuri P Springer; Rebecca J Eisen; Casey Barton Behravesh
Journal:  Am J Trop Med Hyg       Date:  2015-10-26       Impact factor: 2.345

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.